BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank49
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P49
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.87% |
| Q3 2025 | -26.85% |
| Q2 2025 | 3.82% |
| Q1 2025 | -14.54% |
| Q4 2024 | -373.31% |
| Q3 2024 | -172.37% |
| Q2 2024 | 115.13% |
| Q1 2024 | -289.18% |
| Q4 2023 | 349.84% |
| Q3 2023 | 51.54% |
| Q2 2023 | 58.55% |
| Q1 2023 | -995.57% |
| Q4 2022 | -154.57% |
| Q3 2022 | 95.44% |
| Q2 2022 | -189.57% |
| Q1 2022 | 140.92% |
| Q4 2021 | -71.79% |
| Q3 2021 | -641.35% |
| Q2 2021 | 1380.17% |
| Q1 2021 | 40.14% |
| Q4 2020 | 30.30% |
| Q3 2020 | 1.48% |
| Q2 2020 | 62.49% |
| Q1 2020 | -14.24% |
| Q4 2019 | 3.28% |
| Q3 2019 | -11.93% |
| Q2 2019 | 4.03% |
| Q1 2019 | -51.60% |
| Q4 2018 | 51.19% |
| Q3 2018 | -29.04% |
| Q2 2018 | -68.80% |
| Q1 2018 | -54.45% |
| Q4 2017 | 46.37% |
| Q3 2017 | -1.38% |
| Q2 2017 | -182.51% |
| Q1 2017 | 5.48% |
| Q4 2016 | -12.57% |
| Q3 2016 | 9.17% |
| Q2 2016 | 56.86% |
| Q1 2016 | -222.69% |